Panitumumab Market Analysis, Growth Factors and Dynamic Demand by 2034 Panitumumab is a monoclonal antibody used primarily in the treatment of metastatic colorectal cancer. It targets the epidermal growth factor receptor (EGFR), which plays a critical role in the growth and survival of cancer cells. The market for Panitumumab is part of the broader oncology and biologics markets. https://smadake38.medium.com/panitumumab-market-analysis-growth-factors-and-dynamic-demand-by-2034-bb84596cedc4